You may simply be early
Starting doses are chosen for tolerance, not effect, and appetite change precedes weight change. Judging the outcome before titration finishes is the most common version of this problem.
Portions drift quietly
Appetite suppression makes people stop measuring, because measuring feels unnecessary. Two weeks later intake has crept up invisibly. A few days of honest logging usually settles the question faster than any dose change.
Protein, sleep and alcohol do more than people expect
Low protein costs muscle, which lowers daily energy expenditure. Short sleep raises appetite signalling and undermines the medicine you are paying for. Alcohol adds calories and disrupts sleep at the same time.
Semaglutide acts on the GLP-1 receptor – the same signalling your gut uses after a meal.
The scale is a poor instrument for short windows
Water retention, salt, menstrual cycle timing and constipation can hide real fat loss for a week or more. Waist measurement and how clothes fit are often more informative.
Storage and technique can quietly reduce what you receive
A vial that has been warm, frozen or is past its date may not deliver what the label says. So can injecting into muscle or the same over-used spot every week.
What deserves clinical review
Thyroid disease, PCOS, sleep apnea and certain medications all affect weight independently. This is exactly the conversation to have with your clinician rather than adjusting anything yourself. See the 30-second film answers for this medication.
FDA has warned about dosing errors reported with compounded GLP-1 products.
Why progress slows, and what a clinician looks at
Weight change is rarely linear, and a slowdown is the expected shape rather than a failure of the medication. Physiologically, energy requirements fall as body mass falls, so the same intake that once produced a deficit eventually does not. Appetite signalling also adapts. When someone reports a stall, a clinician generally reviews dose and where you are in the titration schedule, protein intake and resistance training as they relate to lean mass, sleep, alcohol, and other medications that affect weight independently. Some of those are adjustable and some are not. What a clinician will not do is promise that a dose increase resolves it. If lean mass is the concern, protecting muscle during treatment goes into what the evidence does and does not support.
How semaglutide works on the GLP-1 receptor
Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
Why side effects are mostly digestive, and mostly early
Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
Answer a few questions. A licensed clinician decides what, if anything, is appropriate.
Frequently asked questions
Should I ask for a higher dose?
Ask for a review. Your clinician decides whether titration, timing, technique or something unrelated is the actual obstacle.
How long before I should worry?
Bring it up at your next check-in rather than waiting months. Earlier information means a better plan.
How do I inject semaglutide?
Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.
Where do you inject semaglutide?
Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.
How long do semaglutide side effects last?
Gastrointestinal effects are dose-related for many people, so they commonly cluster around a dose change and settle as the body adapts. Persistent or severe symptoms are a reason to contact your clinician rather than wait.
Is Wegovy the same as Ozempic?
Both contain semaglutide, but they are separate FDA-approved products with different approved indications and dosing. Neither is the same as a compounded semaglutide preparation, which is not FDA-approved.
Stop guessing at it alone
Bring the details to a licensed clinician and let the plan change. Rx only, refunded if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedWilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002
- Peer-reviewedJastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216
- FDA databaseDrugs@FDA: search approved labeling for semaglutide
- Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Compounded Semaglutide
Same medication, different question.
